Management options for cervical intraepithelial neoplasia

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 25, Issue 5, 2011, Pages 641-651

  Petry, Karl U ^a  

^a Gynaecology and Gynaecologic Oncology ^*  (Germany)

Author keywords

Cervical transformation zone; CIN; Colposcopy management; Conisation; HPV testing; LLETZ

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; COLPOSCOPY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; PAPILLOMAVIRUS INFECTION; PATIENT SAFETY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT INDICATION; UTERINE CERVIX CARCINOMA IN SITU; CANCER GRADING; PATHOLOGY; REVIEW; TREATMENT OUTCOME; UTERINE CERVIX TUMOR; WATCHFUL WAITING;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMANS; NEOPLASM GRADING; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; WATCHFUL WAITING;

EID: 84858267409     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2011.04.007     Document Type: Article

References (43)

1. Ho GYF, Bierman R, Beardsley L et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-428. (Pubitemid 28135669)
2. Castle PE, Schiffman M, Wheeler CM et al. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009; 113: 18-25.
3. Brummer O, Hollwitz B, Böhmer G et al. Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia. Gynecol Oncol 2006; 102: 517-522. (Pubitemid 44353648)
4. Östör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12: 186-192. (Pubitemid 23095196)
5. Petry KU, Böhmer G, Iftner T et al. Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia. Am J Obstet Gynecol 2002; 186: 28-34. (Pubitemid 34093735)
6. Kjaer SK, Sigurdsson K, Iversen OE et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) 2009; 2: 868-878.
7. Paavonen J, Naud P, Salmeron J et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374: 301-314.
8. McCredie MR, Sharples KJ, Paul C et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9: 425-434.
9. Arbyn M, Kyrgiou M, Simoens C et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008; 337. a1284.
10. Kyrgiou M, Koliopoulos G & Martin-Hirsch P. Obstetrics outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006; 367: 489-498. (Pubitemid 43208905)
11. Jordan J, Arbyn M, Martin-Hirsch P et al. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 2008; 19: 342-354.
12. Jordan J, Martin-Hirsch P, Arbyn M et al. European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology 2009; 20: 5-16.
13. Wright Jr. TC, Massad LS, Dunton CJ et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 2007; 11: 223-239.
14. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003 Jun; 188: 1393-1400.
15. Alvarez RD & Wright TC. Effective cervical neoplasia detection with a novel optical detection system: a randomized trial. Gynecol Oncol 2007; 104: 281-289. (Pubitemid 46135655)
16. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ 2009; 339. b2546.
17. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188: 1383-1392.
18. TOMBOLA group et al. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ 2009; 339. b2548.
19. Elit L, Levine MN, Julian JA et al. Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia: a randomized trial in Canada and Brazil. Cancer 2010; 117: 1438-1445.
20. Wright Jr. TC, Massad LS, Dunton CJ et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007; 197: 346-355.
21. Silverman MH, Hedley ML, Petry KU et al. Clinical trials in cervical intraepithelial neoplasia: balancing the need for efficacy data with patient safety. J Low Genit Tract Dis 2002; 6: 206-211. (Pubitemid 35252150)
22. Petry KU, Breugelmans JG, Benard S et al. Cost of screening and treatment of cervical dyskaryosis in Germany. Eur J Gynaecol Oncol 2008; 29: 345-349.
23. TOMBOLA group et al. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ 2009; 339. b2549.
24. Bigrigg A, Haffenden DK, Sheehan AL et al. Efficacy and safety of the large-loop excision of the transformation zone. Lancet 1994; 343: 32-34. (Pubitemid 24017614)
25. Kennedy AW, Belinson JL, Wirth S et al. The role of the loop electrosurgical excision procedure in the diagnosis and management of early invasive cervical cancer. Int J Gynecol Cancer 1995; 5: 117-120.
26. Prendiville W, Cullimore J & Norman S. Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical neoplasia. Br J Obstet Gynaecol 1989; 96: 1054.
27. Mathevet P, Dargent D, Roy M et al. A randomized prospective study comparing three techniques of conization: cold knife, laser, and LEEP. Gynecol Oncol 1994; 54: 175-179. (Pubitemid 24256466)
28. Oyesanya OA, Amerasinghe CN & Manning EAD. Outpatient excisional management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1993; 168: 485-488.
29. Melnikow J, McGahan C, Sawaya GF et al. Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst 2009; 101: 721-728.
30. Nobbenhuis MA, Meijer CJ, van den Brule AJ et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 2001; 84: 796-801. (Pubitemid 32275653)
31. Arbyn M, Ronco G, Meijer CJ et al. Trials comparing cytology with human papillomavirus screening. Lancet Oncol 2009; 10: 935-936.
32. Meijer CJ, Berkhof J, Castle PE et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009; 124: 516-520.
33. Chan BK, Melnikow J, Slee CA et al. Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol 2009; 200: 422-429.
34. Kitchener HC, Walker PG, Nelson L et al. HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia. BJOG 2008; 115: 1001-1007. (Pubitemid 351841763)
35. Alvarez RD, Helm CW, Edwards RP et al. Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasia. Gynecol Oncol 1994; 52: 175-179. (Pubitemid 24064366)
36. Petry KU, Glaubitz M, Maschek H et al. Electrosurgical loop excision of the transformation zone in treatment of cervix neoplasia [In German]. Geburtshilfe Frauenheilkd 1996; 56: 513-516. (Pubitemid 26371735)
37. Carreon JD, Sherman ME, Guillen D et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol 2007; 26: 441-446. (Pubitemid 47476331)
38. van Seters M, van Beurden M, ten Kate FJ et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med 2008; 358: 1465-1473. (Pubitemid 351482738)
39. Khan MJ, Castle PE, Lorincz A et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-Specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97: 1072-1079. (Pubitemid 41417924)
40. Kjaer SK, Hogdall E, Frederiksen K et al. The absolute risk of cervical abnormalities in high-risk human papillomaviruspositive, cytologically normal women over a 10-year period. Cancer Res 2006; 66: 10630-10636. (Pubitemid 44799787)
41. Massad LS, Jeronimo J, Katki HA et al. The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis 2009; 13: 137-144.
42. Fanning J & Padratzik J. Cold knife conization vs. LEEP. Are they the same procedure? J Reprod Med 2002; 47: 33-35. (Pubitemid 34098242)
43. Founta C, Arbyn M, Valasoulis G et al. Proportion of excision and cervical healing after large loop excision of the transformation zone for cervical intraepithelial neoplasia. BJOG 2010; 117: 1468-1474.